Corpus Intelligence IC Memo — GARRISON MEMORIAL HOSPITAL 2026-04-26 05:28 UTC
IC Memo — GARRISON MEMORIAL HOSPITAL
Investment Committee Memorandum | ND | 22 beds | Grade D | EBITDA uplift $748K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

GARRISON MEMORIAL HOSPITAL

CCN 351303 | nan, ND | 22 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

GARRISON MEMORIAL HOSPITAL is a 22-bed community hospital in nan, ND with $10.1M in net patient revenue and a -20.5% operating margin. The hospital serves a payer mix of 43.0% Medicare, 0.0% Medicaid, and 57.0% commercial.

Thesis: Turnaround. Our ML models identify $748K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -20.5% to -13.0% (+742bps).

Net Revenue HCRIS$10.1M
Current EBITDA COMPUTED$-2.1M
Operating Margin COMPUTED-20.5%
Occupancy HCRIS11.0%
Revenue / Bed COMPUTED$458K
Net-to-Gross HCRIS76.0%
Distress Probability MLnan%

2. Market Context & Competitive Position

52
ND Hospitals
-9.3%
State Median Margin
41
Comparable Hospitals

ND has 52 Medicare-certified hospitals with a median operating margin of -9.3%. The target's margin of -20.5% places it below the state median. Among 41 size-comparable peers (11-44 beds), the median margin is -9.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (11-44), prioritizing same-state peers. 41 hospitals in the comp set.

HospitalStateBedsRevenueMargin
GARRISON MEMORIAL HOSPITAL (Target)ND22$10.1M-20.5%
MERCY MEDICAL CENTERND25$85.2M-14.2%
JAMESTOWN REGIONAL MEDICAL CENND25$75.9M1.4%
ST JOSEPHS HOSPITAL & HEALTH CND25$70.0M-0.8%
MCKENZIE COUNTY HEALTHCARE SYSND24$43.1M-20.2%
VIBRA HOSPITAL OF FARGO LLCND31$27.2M46.6%
PAM REHABILITATION HOSPITAL OFND42$26.6M19.0%
MERCY HOSPITALND25$25.9M-9.3%
UNITY MEDICAL CENTERND14$25.7M-0.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $748K (742bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$212K+210bp18mo
Denial Rate Reduction12.0%6.5%$202K+201bp12mo
Cost to Collect4.5%2.5%$202K+200bp12mo
A/R Days Reduction5200.0%3800.0%$123K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+10bp6mo

5. EBITDA Bridge

Net Collection Rate
$212K
Denial Rate Reduction
$202K
Cost to Collect
$202K
A/R Days Reduction
$123K
Clean Claim Rate
$10K
Total EBITDA Uplift$748K
Current EBITDA$-2.1M
+ RCM Uplift+$748K
Pro Forma EBITDA$-1.3M
Current Margin-20.5%
Pro Forma Margin-13.0%
WC Released (1x)$386K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-3.2M$-6.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-3.2M$-7.8M0.00x-100.0%
Bull Case9.0x11.0x$-2.9M$-6.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.9M$-7.7M0.00x-100.0%
Bear Case11.0x10.0x$-3.5M$-8.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-3.5M$-10.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 11.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 41 hospitals with 11-44 beds
  • Same-state prioritization (n=42)
  • Comp margins: P25=-19.7% / P50=-9.0% / P75=-2.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.